RARS1 and non-small cell lung carcinoma: One such study determined the expression of RARs in normal and malignant tissues from 76 patients with NSCLC and showed that tumor cells have overexpressed RXRα and RARα and reduced RXRβ, RARβ, and RARγ [207].